Strides Pharma Science is currently trading at Rs. 428.05, up by 16.70 points or 4.06% from its previous closing of Rs. 411.35 on the BSE.
The scrip opened at Rs. 413.00 and has touched a high and low of Rs. 431.15 and Rs. 413.00 respectively. So far 58596 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 547.35 on 14-Feb-2020 and a 52 week low of Rs. 271.00 on 20-Mar-2020.
Last one week high and low of the scrip stood at Rs. 431.15 and Rs. 407.45 respectively. The current market cap of the company is Rs. 3757.81 crore.
The promoters holding in the company stood at 31.27%, while Institutions and Non-Institutions held 47.68% and 21.05% respectively.
Strides Pharma Science’s step?down wholly owned subsidiary, Strides Pharma Global, Singapore, has received approval for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules, 50 mg/325 mg/40 mg/30 mg from the United States Food & Drug Administration (USFDA). The product is a generic version of Fioricet with Codeine Capsules, 50 mg/325 mg/40 mg/30 mg, of Teva Branded Pharmaceutical Product R&D, Inc.
The US market for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules, 50 mg/325 mg/40 mg/30 mg is approximately $10 million. The product will be marketed by Strides Pharma Inc. in the US market. The company has 124 cumulative ANDA filings with USFDA of which 87 ANDAs have been approved and 37 are pending approval.
Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1520.55 |
Dr. Reddys Lab | 6217.15 |
Cipla | 1405.40 |
Zydus Lifesciences | 953.50 |
Lupin | 1589.10 |
View more.. |